Neutrophil activating peptide 2 or analog thereof is administered to a mammal to achieve {HEAD ~ therapeutic reduction} of the number of {TAIL ~ circulating platelets} 
Neutrophil activating peptide 2 or analog thereof is administered to a mammal to achieve { HEAD ~ therapeutic reduction } of the number of { TAIL ~ circulating platelets }
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL